Implantable Analyte Sensor
Membrane may be fabricated with precisely defined pore size May be fabricated using standard microfabrication techniquesSensor membrane can be fabricated to give a glucose diffusion test result of at least 1 mg/dl in 330 minutes and an albumin diffusion test result of at most 0.1 g/dl in 420 minutes
Implantable glucose sensor
None
Patent Number: US6405066B1
Application Number: US2000528277A
Inventor: Essenpreis, Matthias | Desai, Tejal A. | Ferrari, Mauro | Hansford, Derek J.
Priority Date: 17 Mar 2000
Priority Number: US6405066B1
Application Date: 17 Mar 2000
Publication Date: 11 Jun 2002
IPC Current: G01N0033483 | A61B000500 | A61B0005145 | A61B00051473 | C12M000134 | C12Q000100 | G01N0027327 | G01N002740 | G01N0027416 | G01N003366 | G01N003368
US Class: 600347 | 204415 | 600345 | 600377 | 204403
Assignee Applicant: The Regents of the University of California | Roche Diagnostics Corporationdianapolis
Title: Implantable analyte sensor
Usefulness: Implantable analyte sensor
Summary: Used in vivo , preferably subcutaneously in mammals, e.g. humans, dogs, or mice.
Novelty: Glucose sensor used subcutaneously in mammals, e.g. humans, includes membrane comprising elemental silicon and has specified glucose and albumin diffusion test results
电子
电路设计
Tech ID/UC Case 17009/2001-030-0 Related Cases 2001-030-0
美国
